The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations.
A hypothetical model for estimating the probability of leukemia development, supported by experimental evidence, provides a basis on which the conclusion can be drawn that residual leukemic cells in the graft will not contribute significantly to the occurrence of a leukemia relapse after autologous bone marrow transplantation.